Seer, Inc. (SEER)
$2.11-1.86%Close
BUYRECOVERY · day 13
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $116M
- Beta
- 1.47
- P/E (TTM)
- -1.73
- Short % float
- 0.27%
- Days to cover
- 1.0
- SI change
- +24.4%
- 1W
- -3.65%
- 1M
- +10.47%
- vs SPY 1W
- -3.51%
- vs SPY 1M
- +7.97%
Industry peers
FMP comparable companies · ranked by market cap
- KYMRSELLKymera Therapeutics, Inc.$9.2BBEARQ 25$112.40-4.82%
- NRIXSELLNurix Therapeutics, Inc.$2.3BBEARQ 11$22.35-0.14%
- PHVSSELLPharvaris N.V.$2.2BCRISISQ 15$31.10-2.82%
- MLYSSELLMineralys Therapeutics, Inc.$2.1BCRISISQ 17$23.37-5.53%
- ORICSELLORIC Pharmaceuticals, Inc.$1.2BBEARQ 3$11.99-4.23%
- CGEMSELLCullinan Therapeutics, Inc.$954MCRISISQ 1$15.53-5.69%
- GLUESELLMonte Rosa Therapeutics, Inc.$870MCRISISQ 7$10.30-5.99%
- SANASELLSana Biotechnology, Inc.$776MCRISISQ -6$2.79-8.02%
- STTKSELLShattuck Labs, Inc.$540MCRISISQ 4$5.97-9.85%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on SEER?
- LOPJLB’s latest quantitative signal on Seer, Inc. (SEER) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is SEER in?
- Seer, Inc. (SEER) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Seer, Inc. (SEER) do?
- Seer, Inc. is a life sciences firm specializing in developing and commercializing advanced technologies designed to unravel the complexities of the proteome. At the core of its offerings is the Proteograph Product Suite, an integrated platform comprising specialized consumables, automated instrumentation, and sophisticated software. This comprehensive solution empowers researchers to conduct ad…